tiprankstipranks

Hunter Gillies Insider Profile

4 Followers
Hunter Gillies, CMO at Aerovate Therapeutics, holds 5.60K shares in Aerovate Therapeutics (Ticker: AVTE).
tipranks
Hunter Gillies

Hunter Gillies
Aerovate Therapeutics (AVTE)
CMO

Not Ranked
Hunter Gillies has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$15K
100.00%
A breakdown of Hunter Gillies's holdings

Insider Roles

Aerovate Therapeutics
(AVTE)
CMO
Roles that Hunter Gillies holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Hunter Gillies

Hunter Gillies's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aerovate Therapeutics
Jun 14, 2024
CMO
Uninformative Buy
12.84K
$14.90K
Hunter Gillies has not reported any informative transactions for AVTE, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 15, 2023
Uninformative Buy
$20.88K
-
$1.74
Dec 22, 2023
Uninformative Buy
$6.96K
-
$1.74
Dec 29, 2023
Uninformative Buy
$267.50
-
$2.14
Jan 19, 2024
Uninformative Buy
$6.96K
-
$1.74
Feb 22, 2024
Uninformative Buy
$6.07K
-
$1.74
List of latest transactions for each holding click on a transaction to see Hunter Gillies's performance on stock

Hunter Gillies insider profile FAQ

What is the percentage of profitable transactions made by Hunter Gillies?
The percentage of profitable transactions made by Hunter Gillies is ―.
    What is the average return per transaction made by Hunter Gillies?
    The average return per transaction made by Hunter Gillies is ―.
      What stocks does Hunter Gillies hold?
      Hunter Gillies holds: AVTE stocks.
        What was Hunter Gillies’s latest transaction?
        Hunter Gillies latest transaction was an Uninformative Buy of $12.84K.
          What was Hunter Gillies's most profitable transaction?
          Hunter Gillies’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Hunter Gillies's role in Aerovate Therapeutics?
            Hunter Gillies's role in Aerovate Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.